cefazolin has been researched along with End Stage Liver Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, T; Carpenter, I; Eguchi, S; Hara, T; Hidaka, M; Kinoshita, A; Kitasato, A; Kuroki, T; Soyama, A; Takatsuki, M | 1 |
1 other study(ies) available for cefazolin and End Stage Liver Disease
Article | Year |
---|---|
The impact of treated bacterial infections within one month before living donor liver transplantation in adults.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cefazolin; Drug Therapy, Combination; End Stage Liver Disease; Female; Humans; Incidence; Liver Transplantation; Living Donors; Male; Middle Aged; Perioperative Care; Postoperative Complications; Preoperative Period; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 2014 |